Chambers H F, Sande M A
Antimicrob Agents Chemother. 1984 Jul;26(1):61-4. doi: 10.1128/AAC.26.1.61.
In rabbits with experimentally induced endocarditis, the efficacy of teicoplanin compared favorably both with that of nafcillin for infection by a methicillin-susceptible strain of Staphylococcus aureus and with that of vancomycin for infection by a methicillin-resistant strain of S. aureus. In a 4-day treatment regimen, teicoplanin was as effective as either nafcillin or vancomycin in eliminating organisms from aortic valve vegetations in the respective infection. In a 10-day regimen for methicillin-resistant S. aureus endocarditis, both teicoplanin and vancomycin sterilized the vegetations of some rabbits, but the relapse rate was high for both. These results justify further investigation into the role of teicoplanin for the treatment of serious infections caused by S. aureus.
在实验性诱发心内膜炎的兔子中,替考拉宁的疗效与萘夫西林对甲氧西林敏感金黄色葡萄球菌感染的疗效相比具有优势,与万古霉素对甲氧西林耐药金黄色葡萄球菌感染的疗效相比也具有优势。在为期4天的治疗方案中,替考拉宁在各自感染中从主动脉瓣赘生物清除病原体方面与萘夫西林或万古霉素一样有效。在针对甲氧西林耐药金黄色葡萄球菌心内膜炎的10天治疗方案中,替考拉宁和万古霉素都使一些兔子的赘生物灭菌,但两者的复发率都很高。这些结果证明有必要进一步研究替考拉宁在治疗由金黄色葡萄球菌引起的严重感染中的作用。